Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Nakasono S et al. | 2000 | bacterium, <i>Escherichia coli</i>/K12 | magnetic field, low frequency, 50/60 Hz, co-exposure | 7.8–14 mT |
Akan Z et al. | 2010 | intact cell/cell culture, bacterium, THP-1 cells (human monocytic leukemia cell line) and <i>Staphylococcus aureus</i> | magnetic field, low frequency, 50/60 Hz, co-exposure | 1–5 mT |
Patruno A et al. | 2010 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, low frequency, 50/60 Hz, electrotherapy | 1 mT |
Eleuteri AM et al. | 2009 | intact cell/cell culture, Caco 2 cells (human colon adenocarcinoma cell line) | magnetic field, low frequency, 50/60 Hz, power transmission line | 1 mT |
Yamaguchi DT et al. | 2002 | intact cell/cell culture, ROS 17/2.8 (osteoblast-like cells) and MC3T3-E1 cells (mouse osteoblast-like cells) | magnetic field, low frequency, 50/60 Hz, therapeutic/medical device | 0.6–1.25 mT |
Kavak S et al. | 2009 | animal, rat/Wistar, whole body | magnetic field, low frequency, signals/pulses, 50/60 Hz | 5 mT |
Aldinucci C et al. | 2009 | organelle/cell part, synaptosome suspensions | magnetic field, low frequency, signals/pulses, 50/60 Hz | 2 mT |
Kim YM et al. | 2016 | intact cell/cell culture, B16F10 (murine melanoma cells) | magnetic field, low frequency, signals/pulses, 50/60 Hz | - |
Nindl G et al. | 1997 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, signals/pulses, 50/60 Hz | 0.1–1.8 mT |
Pessina GP et al. | 1998 | intact cell/cell culture, peripheral blood mononuclear cells | magnetic field, signals/pulses, 50/60 Hz | 3 mT |
Aldinucci C et al. | 2007 | organelle/cell part, synaptosome suspensions | magnetic field, signals/pulses, 50/60 Hz | 2 mT |
Sołek P et al. | 2022 | intact cell/cell culture, HeLa cells (human adenocarcinoma cell line) and DU 145 cells (human prostate cancer cell line) | magnetic field, signals/pulses, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Cossarizza A et al. | 1989 | intact cell/cell culture, human peripheral blood lymphocytes | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 2.5 mT |
Davies E et al. | 2000 | intact cell/cell culture, slime mold <i>Dictyostelium discoideum</i> | magnetic field, signals/pulses, 50/60 Hz, low frequency, therapeutic/medical device | 0.4–3 mT |
Kula B | 1996 | intact cell/cell culture, mouse fibroblasts | magnetic field, static magnetic field, 50/60 Hz | 20–490 mT |
Liu J et al. | 2024 | intact cell/cell culture, <i>Aspergillus niger</i> | magnetic field, static magnetic field, 50/60 Hz | - |
Salerno S et al. | 2009 | intact cell/cell culture, human t-lymphocytes | magnetic field, static magnetic field, 50/60 Hz, DC | 0.5 mT |
Potenza L et al. | 2012 | intact cell/cell culture, truffle mycelium <i>Tuber borchii</i> | magnetic field, static magnetic field, 50/60 Hz, DC | 0.1–300 mT |
Mizukawa Y et al. | 2013 | intact cell/cell culture, slime mold <i>Physarum polycephalum</i>, MC3T3-E1 cells (mouse osteoblast-like cell line) | magnetic field, static magnetic field, 50/60 Hz, also other exposures without EMF | 1 mT–5 T |
Jabłońska J et al. | 2022 | bacterium, <i>Pseudomonas aeruginosa</i> | magnetic field, static magnetic field, 50/60 Hz, low frequency | - |
Blumenthal NC et al. | 1997 | intact cell/cell culture, rat tendon fibroblasts and rat bone marrow osteoprogenitor cells (Sprague-Dawley rat) | magnetic field, static magnetic field, intermediate frequency, 50/60 Hz | 0.25–0.5 mT |
Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
Calabrò E et al. | 2019 | intact cell/cell culture, SH-SY5Y cells (human neuroblastoma cell line) | static magnetic field, 50/60 Hz, magnetic field, DC | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.